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Upon maturation, primary rat oligodendrocytes become resistant to coronavirus JHM (JHMV) infection at an early stage.
Involvement of cAMP-dependent protein kinase (PK) in the regulation of oligodendrocyte differentiation has been established
(S. Beushausen et al. (1987). J. Virol. 61, 3795–3803). An inducer which accelerates maturation, dibutyryl cyclic AMP
(dbcAMP) also upregulates the expression of the regulatory subunit, R1 of PK1. Since (i) early block preventing infection of
mature oligodendrocytes can be bypassed when transfection with genomic RNA is used and (ii) inhibitors of PKs counteract
the dbcAMP effect, so as to alleviate the inhibition of JHMV, enhanced expression of R1 appeared to be connected with
virus restriction. This idea was confirmed following upregulation of the R1 gene in fully permissive L-2 cells. There was a
connection between an effect due to R1 and dephosphorylation of the nucleocapsid protein N by an endosomal phosphopro-
tein phosphatase (PPPase) having the properties of types 1 or 2A enzyme which occurs during penetration of inoculum
virions. An inhibition in vitro (cell free) of N dephosphorylation by R1 together with evidence that in vivo (cell culture)
overexpression of R1 inhibited the endosomal PPPase as well as replication of JHMV supports the hypothesis that uncoating
of the JHMV inoculum occurs after dephosphorylation, a step obligatory for dissociation of the N protein from the genome.
Thus inhibition by R prevents uncoating and thereby interferes with the commencement of replication. These observations
intimate the existence of a novel mechanism controlling a virus infection of specific cell target(s) undergoing a process of
differentiation and maturation in the central nervous system. q 1996 Academic Press, Inc.
INTRODUCTION 1982; Robbins and Rapp, 1980), but neural cell infections
with rubella virus (Van Alstyne and Paty, 1983) and poly-
The appearance and type of neurological disease ap- oma virus (Baru and Manor, 1988) are enhanced. In the
parent in the central nervous system of rats inoculated above systems the cAMP effect has not been explained,
with the neurotropic coronavirus JHM (JHMV) is related although previous evidence (Beushausen et al., 1987)
to the postpartum age at challenge. Onset of resistance has suggested that the regulatory (R) subunit of cAMP-
to a demyelinating form of white matter disease occurs dependent protein kinase (PK) may somehow be in-
around the time that CNS myelination is at the stage of volved.
completion and may be due to the paucity of undifferenti- With respect to gene expression as it may be con-
ated progenitor cells of the oligodendrocytic lineage (Sor- nected to differentiation, elevation of intracellular cAMP
ensen et al., 1980). This presumption is in line with data is believed to increase amounts of the cAMP-dependent
from in vitro studies revealing that JHMV replication is PKs of type 1 (PK1) and 2 (PK2) (Beushausen et al., 1985;
arrested at an early stage when explanted oligodendro- Flockhart and Corbin, 1982; Scott, 1991; Rubin and Ro-
cytes are allowed to mature slowly or are driven into sen, 1975). However, when Wistar Furth (WF) primary
rapid differentiation by modulation of the adenylate cy- oligodendrocytes, from which the PK1 isoform is absent,
clase metabolic pathway (Beushausen and Dales, 1985; are induced to differentiate by application of dbcAMP,
Beushausen et al., 1987; Wilson et al., 1986). It is known R1 is massively induced without increasing PK2 activity
that infection of neural cells by other agents can also be (Beushausen et al., 1987). While the assumed function
influenced, either positively or negatively, by elevation of of R as a component of the holoenzyme is to form a
intracellular cAMP. In the case of measles, infection of reversible complex with the catalytic (C) subunit, thereby
neuroblastoma cells is suppressed (Miller and Carrigan, controlling phosphorylating activity, the R2 of PK2 was
shown to exert a second property, as an inhibitor of some
phosphoprotein phosphatase(s) (PPPase) (Jurgensen et
1 Current address: Jeneil Biotech. Inc. Milwaukee, WS. al., 1985; Khatra et al., 1985; Shenolikar, 1994; Srivastava2 Current address: Allelix Biopharmaceutical Inc. Mississuaga, Ont.
et al., 1988).3 Present affiliation is Rockeffeller University, New York. Address
Primary oligodendrocytes are susceptible to JHMV atcorrespondence and reprint requests to author at 262 Central Park
West, Apt. 4C, New York, NY, 10024. Fax: 212-787-7139#1. a distinct stage during their differentiation, between the
33
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 8154 / 6a1f$$$741 10-07-96 12:10:35 viras AP: Virology
34 KALICHARRAN ET AL.
period they are in a highly proliferative O-2A progenitor cubation for 10 hr at 377, the supernatant containing prog-
eny virus was titrated on L-2 cells.phase and the time they become fully mature oligoden-
drocytes (Pasick and Dales, 1991). The block in virus The effect of calyculin A on the processing of N within
the virus inoculum was determined using confluent L-2replication found with oligodendrocytes at an early stage
in the viral cycle, before onset of transcription but after cultures pretreated 30 min prior to JHMV absorption at
47 for 60 min using various concentrations of the drug.adsorption, does not occur in fully permissive L-2 fibro-
blasts, which served as the controls throughout the pres- After 1 hr incubation at 377, following absorption, the
cytoplasmic fraction was processed for immunoblottingent investigation. Previous studies revealed that during
virus assembly the nascent N protein of JHMV becomes with anti-N antibodies.
phosphorylated on serine residues, which is the only
Preparation of purified N proteinposttranslational modification to occur (Cheley and An-
derson, 1981; Stohlman et al., 1983; Wilbur et al., 1986). Isolation of unlabeled and 32P-labeled N protein from
Conversely, during virus disassembly and uncoating, N infected L-2 mouse fibroblasts conformed to procedures
undergoes a molecular weight reduction from 56 to 50 previously described by Mohandas and Dales (1991).
kDa, perhaps due to specific dephosphorylation of N by
an endosome-associated PPPase (Mohandas and Dales, Photoaffinity labeling of R subunit in cell extracts
1991), evidently an essential step for initiation of the
After treatment with H-8 and/or dbcAMP, individualJHMV replication cycle. This study was concerned with
cultures of 2 1 106 oligodendrocytes per 35-mm plateregulation over virus infections by host cells from the
were rinsed twice with ice-cold PBS, the cells were re-central nervous system (CNS), exemplified by interac-
leased by scraping and collected into pellets, then resus-tions between JHMV and differentiating oligodendro-
pended at 07 in 500 ml buffer containing 10 mM Tris–cytes.
HCl at pH 7.4, 1 mM ethylene glycol-bis-(a-aminoethyl
ether)N,N,N*,N*-tetra acetic acid (EGTA), and 50 mg
MATERIALS AND METHODS PMSF/ml. Thorough cell disruption was effected by
squeezing the cell suspension repeatedly (110) throughCulture of L cells, preparations of virus, and assays
a No. 30 gauge needle of a 1-ml hypodermic syringe. The
Details concerning L-2 cell cultures, preparation of homogenates obtained were frozen and thawed twice,
JHMV stocks, methods of virus infection, and plaque sedimented at 15,000g for 10 min using an Eppendorf
assays were as previously described (Beushausen and microfuge at 47. The cytosol fraction was affinity-labeled
Dales, 1985). with 8-azido-[32P]cAMP (61.4 Ci/nmol; ICN Pharmaceuti-
cal Inc., Irvine, CA) as described (Budzilowicz et al.,
Treatment of cells with protein kinase and 1985). Autoradiograms were prepared after separating
phosphatase inhibitors the proteins in 10% SDS–PAGE gels (Laemmli et al.,
1970).Primary WF cultures enriched over 90% with respect
to oligodendrocytes were established from cerebral corti-
Preparation of catalytic and regulatory subunits from
ces of neonatal rats as in Beushausen and Dales (1985).
the holoenzyme and PK1 assay
Multiwell dishes containing 5 1 105 cells per cm2 were
maintained for 3 days at 377 in modified basal Eagle’s Affinity columns were employed to separate the R and
C subunits, as previously outlined (Beavo et al., 1974).medium plus 10% fetal calf serum (BME10) or in BME10
supplemented with dibutyryl cAMP (dbcAMP) (Sigma) Briefly, dehydrated preparations of rabbit PK1 (Sigma)
were reconstituted in distilled water to give a final con-and/or with the protein kinase inhibitors H-8 and HA1004
(Seikagaku Kogyo Co.) (Hidaka et al., 1984). For the sub- centration of 5 mg/ml. The material was introduced into
columns of 5 ml packed volume containing N6-2C-cAMPsequent inoculation, JHMV was used at a multiplicity of
infection (m.o.i.) of 1 plaque forming unit (PFU) per cell. sepharose preequilibrated with buffer containing 5 mM
2-[N-Morpholino] ethane sulfonic acid (MES), 9 mM NaCl,Virus was adsorbed at 377 for 1 hr, cells washed 31
with 1 ml phosphate-buffered saline (PBS), pH 7.2, and 15 mM B-ME, pH 6.5, termed MES buffer. The columns
were then washed at 207 with 2 M NaCl in MES buffer,incubated at 377 in BME10, with supplements where ap-
propriate. Extracellular JHMV was quantitated in the me- followed by washes with MES buffer alone. The C subunit
was eluted in the void volume and concentrated on Ami-dium, which was changed daily, as previously described
(Lucas et al., 1977). con YM-10 membranes as outlined below. To elute R1
from the columns, 3 vol of 30 mM cAMP in MES bufferConfluent L-2 cells in 35-mm dishes were either
treated for 30 min before JHMV inoculation at 47 for 60 were added during incubation for 1 hr at 307. The eluate,
containing R1, was concentrated by Amicon YM-10 mem-min or 2 hr after inoculation with various concentrations
of calyculin A (Research Biochemical Inc., MA). After in- brane and dialyzed at 47 for 2 days with 4 1 1 liter
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changes of MES buffer. Protein determinations were per- through a syringe needle only 5 rather than 10 cycles
and sedimented for only 5 min to remove the larger par-formed using a Bio-Rad kit with BSA as standard. Another
preparation of R1, employed as a control, was obtained ticulate. Membranes in the cytosol fraction were dis-
rupted by means of NP-40 added to a final concentrationfrom skeletal muscle of Wistar rats (a gift from B. D.
Sanwal, Department of Biochemistry, UWO). of 0.5%, and brief agitation on a vortex mixer followed by
15 min at 47 on a rotary mixer. Proteins in the fractionsSamples of isolated C and R subunits were analyzed
for presence of residual PK activity, using histone IIA were separated by SDS–PAGE then transferred to nitro-
cellulose filters for Western blotting (Towbin et al., 1979);(Sigma) as substrate by the procedure of Corbin et al.
(1975); briefly, 84 mM KH2PO4 , pH 6.8, 28 mM Mg acetate, N antigen was identified with monoclonal (MAb) as in
Beushausen et al. (1987).1.75 mM ATP, histone IIA at 50 mg/ml, 10 mM cAMP, and
H2O was mixed with an equal volume of 50 mCi [
32P]ATP
(Amersham; sp act 75,000 Ci/mmol). Then, 50-ml aliquots Specificity of binding between N protein and cDNA
of the above mixture were added to approximately 3 mg
PK protein in glass tubes, incubated for 15 min at 307, Specific binding of N with a cDNA copy of the gene
was tested using the overlay method of Robbins et al.then ‘‘spotted’’ onto GF/C glass fiber filters (Millipore).
The reaction was terminated by immersing the filters in (1986). After immobilizing N in nitrocellulose, the blots
were rinsed for 30 min with standard binding buffer (SBB)10% ice-cold trichloroacetic acid (TCA) and extraction
achieved by agitation for 1 hr on a shaker apparatus. consisting of 0.05 M NaCl, 1 mM disodium EDTA, 10 mM
Tris–HCl at pH 7, 0.02% BSA, 0.02% Ficoll, and 0.02%Following three washes with TCA the filters were rinsed
twice with 100% ethanol and dried at 0207. The [32P]dpm polyvinyl pyrolidone (PVP-360), incubated for 90 min at
room temperature with 32P-labeled plasmid cDNA probewere determined in a scintillation counter.
plus calf thymus DNA, washed 61 or more with SSB over
Isolation of the endosomal fraction and PPPase assay a 60-min period, then air-dried. Autoradiograms were ob-
tained by exposing X-ray film in the presence of an inten-
The endosomal/prelysosomal fractions were isolated
sifying screen. The cDNA was constructed from plasmid
from disrupted L-2 cells by use of a dual percoll gradient
G344 recombined with 1800-bp cDNA from the N gene
procedure and characterized with respect to the enzyme
of CV A59 (Budzilowicz et al., 1985), kindly provided by
activities as previously described (Mohandas and Dales,
S. Weiss (University of Pennsylvania, Philadelphia, PA).
1991). Enzyme assays included those for acid phospha-
Labeling of plasmid DNA with [32P] as described pre-
tase and a ‘‘neutral’’ PPPase with specificity for N as a
viously (Feinberg and Vogelstein, 1983) and purification
substrate. Where appropriate the additions were 1 mM
by means of a spin column according to Maniatis et al.,
3*5* cAMP and 3 mg of either PK holoenzyme or regula-
(1982).
tory (R) or catalytic (C) subunits. The mixtures were prein-
cubated for 30 min at 307. The 32P-labeled or unlabeled
Transfections with RNA of JHMVN was then added and the reaction continued at 307 for
a further 90 min. The reactions were terminated by addi-
The genomic RNA was derived from JHMV propagated
tion of 1% BSA and 25% TCA. The released [32P]dpm
on confluent L-2 monolayers in 150-cm2 flasks. After inoc-
were determined as described previously (Mohandas
ulation using an m.o.i. of 1 for 60 min at 207, growth
and Dales, 1991).
medium was added and incubation carried out at 377
until the monolayer became about 95% virus-inducedImmunoblotting to demonstrate modulation
syncytium. Virus released into the supernatant was col-of the N antigen
lected by centrifugation and used for preparing genomic
RNA as described previously (Banner et al., 1990). ForL-2 monolayers were inoculated with JHMV at an m.o.i.
of about 50 PFU/cell. After adsorption at 47 for 60 min transfection, 5 mg of RNA was combined with 15 ml of
Lipofectin (Life Technologies) and 200 ml Opti MEM (Lifeunattached virus was removed by thorough washing with
cold BME10. Penetration was initiated by incubation in Technologies). After gently mixing the reagents, the RNA
was added to purified primary oligodendrocytes, pre-fresh BME10 at 377. Cultures were sampled at intervals
for 120 min, commencing with a sample taken at the end pared as described by Pasick and Dales (1991) and
seeded at from 2.5 to 5.0 1 105 cells per cm2. Experimen-of adsorption, designated tO. At the time of sampling,
monolayers were washed twice with cold PBS, the cells tal cultures were treated with 3 mM dbcAMP for 24 hr.
As an additional control, L-2 cultures were transfectedwere scraped off and placed into 500 ml of ice cold buffer,
containing 10 mM Tris–HCl at pH 7.4, 1 mM EGTA, 50 in the same manner. The cells were exposed for 12 hr
to the RNA transfection mixture and then growth mediummg/ml PMSF, and 2 mg/ml leupeptin (TPEL). A cytosol
fraction was derived from infected cells as above under was added and supernatants fluid monitored at 48 and
72 hr for the virus progeny released.‘‘Photoaffinity labeling’’ except that cells were squeezed
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TABLE 1
Transfection of Mature, Primary Oligodendrocytes with RNA of JHMV
Titer (PFU/ml)a
48b 72 48 72
Treatment of cells Infection Transfection
Untreated 1,300 { 125 4,680 { 250 30 { 5 50 { 7
1 mM dbcAMP postinfection 3,340 { 208 10,000 { 270 ND ND
1 mM dbcAMP before infection 0 0 10 { 5 30 { 14
L-2 cellsc 38,000 { 900
a Mean of three experiments with standard deviation. ND, not done.
b Hours postinfection.
c Titer with L-2 cells  107 PFU/ml within 24 hr. Oligodendrocyte cultures were treated with 1 mM dbcAMP either 24 hr before addition of 2 PFU/
cell or viral RNA or 48 hr after inoculation. Supernatant virus was titrated on L-2 cells.
Transfection of L-2 cells with the R1 gene previous results demonstrating that the restriction occurs
at an early step, prior to onset of transcription, isolated
Multiple copies of the DNA of the rat R1 gene, which
JHMV genomic RNA was transfected into primary telen-
had been cloned into the vector HL-REV (Corell et al.,
cephalic cultures established as previously described
1989), were used for transfecting semiconfluent cultures
(Pasick and Dales, 1991) from neonatal Wistar Furth
of L-2 cells, as described above. After incubation with
pups. After 8–10 days in culture, the more loosely adher-
the plasmid for 72 hr, the cells were released and subcul-
ent O-2A lineage cells, which can be released by sharply
tured with growth medium containing 500 mg G418 (Life
tapping the culture flask, were plated into fresh growth
Technologies). Stable individual transfectants (clones)
medium and then treated with 1 mM dbcAMP either 24
were selected, grown into cultures for assaying the quan-
hr before inoculation or 2 days following inoculation with
tity of R1 expressed by each clone, employing anti-R1
JHMV. As shown in Table 1, pretreatment of cultures to
antibodies for immunoblotting. As a control the wild-type
induce oligodendrocyte maturation completely blocked
cells were transfected with the plasmid from which the
replication, whereas posttreatment had no effect as com-
R1 gene was absent. The high producer clones 1.2 and
pared with untreated cells, confirming our previous data
1.1 were amplified and challenged with JHMV to deter-
(Beushausen et al., 1987). To circumvent events related
mine their infectability. Efficiency of virus replication was
to penetration and uncoating connected with inoculum
determined by the PFU present in the supernatant at 10
virions, virus genomes were introduced by transfection.
hr PI. Changes in MW of N during the early stages of
The genomic RNA was isolated, combined with Lipofec-
virus–cell interactions were monitored by precooling (47)
tin (Gibco), and added to mature oligodendrocyte cul-
of host cells and then inoculating them for 60 min at 47
tures made nonpermissive by pretreatment with dbcAMP.
at an m.o.i. of 10 PFU/cell. The unattached inoculum was
Such transfected cells were infectable and were able to
washed away, warm nutrient medium added, then incu-
replicate JHMV as compared with controls inoculated
bation carried out for 1 hr. Samples were taken and pro-
with virions (Table 1), demonstrating as previously sug-
cessed for immunoblotting.
gested (Beushausen et al., 1987) that restriction does,
indeed, pertain to an early event. Inevitably, the efficiency
RESULTS of infecting with isolated RNA was much lower than with
virions, less than 1%, as evident with both L-2 cells andDo glial cells exert control over the virus infection at
primary oligodendrocytes (Table 1). The relatively smallan early stage?
but consistent disparity between yields from untreated
JHMV has a tropism for explanted rat oligodendro- oligodendrocytes and those treated postinoculation with
cytes, although infectability is confined to a discrete dbcAMP, reported previously (Pasick and Dales, 1991),
stage in the differentiation process, sometime between remains unexplained.
the mitotically active progenitors (O-2A cells) and termi-
Effect of PK inhibitors on JHMV replicationnally differentiated oligodendrocytes (Pasick and Dales,
in oligodendrocytes treated with inducers1991). Permissiveness is apparently determined by intra-
of differentiationcellular factor(s) acting after adsorption, which itself is
not affected when the nonpermissive cells are chal- The previously made connection relating modulation
of the cAMP dependent-PK(s) caused by dbcAMP withlenged (Beushausen et al., 1987). To elaborate on our
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oligodendrocyte differentiation and inhibition of coronavi-
rus expression (Beushausen and Dales, 1985; Beus-
hausen et al., 1987; Wilson et al., 1986) led us to question
whether PK inhibitors can counteract the dbcAMP effect
and alleviate the restriction on virus replication. The an-
swer was sought by pretreating WF oligodendrocytes
with two isoquinoline sulfonamide derivatives, H-8 and
HA1004 (Hidaka et al., 1984), which are able to inactivate
cAMP-dependent PKs by binding to the C subunits.
As a confirmation of our previous findings and a control
for the inhibition of infection due to differentiation, cul-
tures of oligodendrocytes were pretreated with 1 mM
dbcAMP before inoculation. It is evident in Fig. 1A that
due to pretreatment, JHMV titer was reduced by 80%
within 24 hr and over 90% in 48 hr. Application of 3 mM
FIG. 2. Suppression by the PK inhibitor H-8 of R1 induction in oligo-dbcAMP caused almost complete virus suppression in
dendrocytes treated with dbcAMP. About 2 1 106 oligodendrocytes per
48 hr (Fig. 1B). By contrast, after simultaneous exposure 35-mm plate were cultured in BME10 and for 3 days in the presence
of oligodendrocytes to 1 mM dbcAMP and 25 mM H-8 of either 25 mM H-8 or 1.5 mM dbcAMP or in the presence of both
compounds. For dual treatment H-8 was added 1 day prior to dbcAMP.the virus was replicated by 48 hr at the same rate as in
The cells were harvested and prepared for photoaffinity labeling with
8-azido-[32P]cAMP as described under Materials and Methods. Lane
1, commercially obtained (Sigma) 4 mg cAMP-dependent PK1; lane 2,
untreated cells; lane 3, grown in presence of H-8; lane 4, exposed to
presence of dbcAMP; lane 5, treated with H-8 / dbcAMP. The lower
MW R1 band evident with the purchased PK1, in lane 1, is presumably
a degradation product.
the untreated controls (Fig. 1A). After similar treatment
with 3 mM dbcAMP the addition of 25 mM H-8 was able
to relieve the inhibition only partially, as shown in Fig.
1B. The other inhibitor of PK, HA1004, when added at 50
mM together with 1 mM dbcAMP reversed the dbcAMP
effect during the initial 24 hr of the experiment (Fig. 1A).
However, simultaneous treatment with 3 mM dbcAMP
and HA1004 affected the inhibition of JHMV replication
very little (Fig. 1B).
To ascertain independently whether reversal of the
inhibitory effect due to dbcAMP on JHMV replication by
H-8 involves the PK’s, oligodendrocytes were treated with
either the inducer or the inhibitor or with both com-
pounds. It is evident from lanes 2 and 4 of the autoradio-
gram in Fig. 2 that, as predicted from Beushausen et al.
(1987), dbcAMP induced the synthesis of large amounts
of R1. Treatment with H-8 alone did not appreciably de-
crease the quantity of R1 present in controls (lane 2 vs
3). When both H-8 and dbcAMP were added R1 induction
was abrogated (lane 5), demonstrating that in oligoden-
drocytes presence of low amounts of R1 appears to be
FIG. 1. Effect of protein kinase inhibitors on JHMV replication in
correlated with permissiveness of JHMV and vice versa.cultures of glial cells induced to differentiate with dbcAMP. (A) cultures
Taken together, the above findings offer evidence sup-of glial cells at 2.5 1 105 cells per cm2 were pretreated for 3 days with
1 mM dbcAMP, 1 mM dbcAMP / 25 mM H-8, or /50 mM HAI004 porting the hypothesis that in differentiating oligodendro-
prior to inoculation with JHMV, m.o.i. 1 PFU/cell. The culture fluid was cytes modulation of PK(s) is connected with inhibition of
assayed for infectivity at the times indicated. Data are expressed as
JHMV expression at an early stage in the replicationpercentage of virus produced in the controls, usually 5 1 102 –103 PFU/
cycle, which can be bypassed upon transfection withml. (B) Experimental conditions as in (A) except that dbcAMP was
added at 3 mM. genomic RNA.
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The above results led us to extend our enquiry into
changes in phosphorylation of N during virus penetration,
specifically whether dephosphorylation is required for ini-
tiating JHMV replication. For this purpose, we employed
calyculin A, a reversible inhibitor of PPPases (Ishihara et
al., 1989). L-2 cells were treated with the drug for 30 min
either before inoculation or 2 hr after initiating penetration.
As a measure of JHMV replication, titers of virus released
by 10 hr postinfection into the medium were determined.
As evident from Fig. 4, when 100 nM calyculin A was
applied in advance of inoculation, the JHMV titer was re-
duced about 1.5 log10 PFU/ml as compared with virus
generated by cells treated with calyculin A commencing
2 hr postinfection. These data are consistent with the idea
that dephosphorylation by a PPPase activity may be re-FIG. 3. Molecular Weight modulation of JHMV N protein during initial
120 min of JHMV penetration into L-2 cells. Infection of L-2 cells, prepa- quired to promote virus replication. To relate this evidence
ration of samples, and immunoblotting are described under Materials with any in vivo effect of calyculin A on phosphorylation
and Methods. of N, L-2 cells were treated with various concentrations
of the inhibitor prior to inoculation as described for Fig. 4.
Samples taken 1 hr postinoculation were subjected toEvidence that MW modulation of N is related to the
immunoblotting employing anti-N antibodies. As evidentstate of phosphorylation
from Fig. 5, conversion of N from the 56- to 50-kDa MW
form was reduced by calyculin A in a concentration-de-A relationship between the 56-kDa N present within
virions and a related 50-kDa protein was previously es- pendent manner, as was to be anticipated if dephosphory-
lation of N was being affected. From these combined re-tablished using 2-D tryptic peptide mapping (Cheley and
Anderson, 1981) and anti-N monoclonal antibodies (MAb) sults, it was concluded that dephosphorylation of N is an
early event during virus–cell interactions which may be(Coulter-Mackie et al., 1985). Upon its synthesis, N be-
comes phosphorylated at serine residues (Stohlman et essential for commencement of replication.
To connect more directly dephosphorylation of the 56-al., 1983; Wilbur et al., 1986). To determine whether MW
modulation of N following its synthesis is due to phos- kDa form of N with an endosomal PPPase activity, in
vitro assays were conducted. As shown in Fig. 6, afterphorylation, the nutrient medium of infected cultures was
varied in the phosphate concentration. The 50-kDa spe-
cies of N was reduced in proportion to increasing phos-
phate concentration, being absent when phosphate was
at 5 mM (data not shown), demonstrating a regulation of
the relative amounts of 50- and 56-kDa N protein in in-
fected cells by phosphate concentration in the growth
medium. The 56-kDa MW of N is the predominant form
within mature JHMV particles.
From previous evidence suggesting that N is modified
during JHMV penetration, MW of the inoculum N protein
was ascertained by immunoblotting at intervals for the
first 120 min. The results shown in Fig. 3 indicated that
between t0 and 30 min after warming to 377, N existed
predominantly as the 56-kDa species. At 45 min, there
was some processing of the 56-kDa antigen evident as
several lower MW bands, including one at 50 kDa and
some below 40 kDa. At 60 min, the 56-kDa material was
completely absent and only a faint 50-kDa band re-
mained while the remainder of N was at lower MW. By
120 min, the N antigen had disappeared altogether.
FIG. 4. Effect of calyculin A on JHMV replication. A range of calyculinThese observations established that during the time-
A concentrations were added to the BME10 either 30 min prior to
course of JHMV penetration, N was reduced from 56 or 2 hr after virus inoculation. The PFU/ml in supernatant fluid were
to 50 kDa and subsequently hydrolyzed to lower MW determined in samples taken 10 hr after inoculation. Pretreated, closed
circles; treated after inoculation, open squares.components.
AID VY 8154 / 6a1f$$$743 10-07-96 12:10:35 viras AP: Virology
39CONTROL OF CORONAVIRUS UNCOATING
FIG. 7. Effect of a PPPase inhibitor on the processing of N in the
presence of endosomes as revealed in (A) nucleic acid binding assays
FIG. 5. Inhibition of N processing by calyculin A. L-2 cells were and in (B) by immunoblotting. Purified N protein was exposed to endo-
pretreated for 30 min with calyculin A prior to inoculation. Two hours somes. [32P] nucleic acid binding assay and Western blotting were
after addition of virus, cell samples were taken for immunoblotting performed as described under Materials and Methods. Lane 1, N en-
employing anti-N antibodies. zyme absent; lane 2, E, endosomal fraction only; lane 3, NE/H in the
presence of heat-inactivated endosomes; lane 4, NE, normal reaction
with active endosomes; lane 5, NE/OA with endosomes and okadaic
adding 56-kDa N to the endosomal fraction, the amount acid, following pretreatment for 30 min with okadaic acid; lane 6, NE/
PI with endosomes and protease inhibitor, after pretreatment for 30of this material converted into a lower MW form was
min with TPEL.increased according to the quantity of endosomes used.
When 32P-labeled N was reacted with endosomes in the
same manner, about one-half of the protein bound [32P]
culin A, acting as a specific inhibitor of neutral PPPases,
was solubilized (Mohandas and Dales, 1991). Evidently,
depressed the conversion of 56 to 50 kDa (lane 5 in Figs.
conditions used for the in vitro assays were appropriate
7A and 7B). Since the MW shift was unaffected in the
for demonstrating that dephosphorylation of N brings
presence of protease inhibitors in the reaction mixture,
about a shift down of the MW.
the observed change in MW of N must have been due
As a confirmatory approach for detecting the MW mod-
to dephosphorylation, not proteolysis. From the above
ulation of N due to the endosomal PPPase activity, we
observations, it was concluded that, during the interac-
correlated the binding of a radioactive cDNA probe with
tion of JHMV with host cells, the dephosphorylation of N
the N antigen, bound to nitrocellulose as detected by
by an endosomal PPPase most probably causes the 56-
immunoblotting. Samples were monitored following incu-
to 50-kDa MW conversion, as a step in the uncoating of
bation with the endosomal fraction, as described above.
inoculum genomes.
The results presented in Fig. 7A indicated that the cDNA
copied from N RNA could recognize both the 56- and 50- Inhibition of endosomal PPPase activity by the R
kDa forms of N in an nondiscriminating manner. How- subunit of cAMP-dependent PKs
ever, a specific binding of the 56-kDa form of N to viral
We obtained evidence in this study that N is dephos-RNA has been noted (Baric et al., 1988). The specificity
phorylated during JHMV penetration into L-2 cells. Bothof the endosomal PPPase activity for N as a substrate
previously and in the present study, it was demonstratedwas checked by means of okadaic acid which, like caly-
that an endosome-associated PPPase of L-2 and glial
cells can specifically dephosphorylate N in vitro (Mohan-
das and Dales, 1991), indicating that this enzyme activity
has a function during the interaction between JHMV and
explanted oligodendrocytes. Since inducers of differenti-
ation, among them cAMP, can regulate PK expression
and suppress JHMV replication in oligodendrocytes at
an early stage (Beushausen and Dales, 1985; Beus-
hausen et al., 1987), it was hypothesized that PK, or one
of the holoenzyme components, can influence the endo-
somal PPPase. This idea is consistent with the well-
recognized interplay between PKs and PPPases in meta-
bolic pathways involving these enzymes (for reviews, see
FIG. 6. Effect of endosomal fraction on the in vitro processing of Cohen, 1989; Ingebritsen and Cohen, 1983; Shenolikar,
N monitored by immunoblotting. Purified N was treated with varying 1994). When the dose–response effect of R1 was exam-
amounts of the endosomal preparation and then monitored by immu- ined, it became evident that R1 inhibits the endosomal
noblotting. (A) 0.5 mg of purified N; (B) 1.0 mg of purified N. Lane 1,
PPPase to almost the maximum extent at 3 mg. Increas-untreated N; lanes 2, 3, and 4, N incubated with, respectively, 10, 20,
ing R1 up to 12 mg caused only very little additionaland 40 ml of the endosomal fraction. Duration of exposure to X-ray film
was 48 hr in A and 24 hr in B. inhibition of N dephosphorylation (data not shown).
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TABLE 2 in mature oligodendrocytes led us to test whether overex-
pression of R1 in a nondifferentiating, fully permissiveDephosphorylation of N Protein by an Endosomal PPPase in the
continuous line of host cells can also influence the JHMVPresence of PK and Enzyme Subunits
infectious process. For this purpose, plasmids encoding
Activity as % the rat R1 gene were transfected into L-2 cells. Stable
dephosphorylation/25 mg transfectant clones were established and selected in the
Addition endosomala protein % Inhibitionb
presence of G418 for comparison with normal L-2 cells
for levels of R1 expression by means of immunoblottingNone 36 (9) 0
PK1 holoenzyme 37 (4) 0 employing anti-R1 antibodies, as illustrated in Fig. 9C.
PK1 holoenzyme / cAMP 31 (5) 14 { 3.2 Influence of the amount of R1 expressed on virus replica-
PK2 holoenzyme 37 (2) 0 tion was determined by titration of JHMV present in the
PK2 holoenzyme / cAMP 28 (4) 22 { 2.6 supernatant at 8 hr PI. As shown in Fig. 9B, PFU/ml ofR1 3 mg 24 (3) 33 { 2.7
JHMV produced by cells overexpressing R1 was aboutR1 3 mg / cAMP 19 (9) 47 { 7.0
C1 5 mg / cAMP 42 (4) 0 1.5 log10 lower than in untransfected L-2 cells. To exam-
ine the in vivo effect of R1 on modulation of N within
a Data from a representative experiment repeated the number of inoculum virions, cells taken at 2 hr postinoculation were
times shown in brackets. One unit of activity is defined as 1% of [32P]
processed for immunoblotting with anti-N antibodies. Asreleased in 90 min at 307.
evident from Fig. 9A, N processing from 56 to 50 kDab Average values with standard error of the mean.
was inhibited at an early stage of replication in the
transfectant clones, with a greater restriction evident in
Effects of adding PK1, PK2, R1, or C subunits to the the higher R1 expressing clone 1.2 (Fig. 9C). These find-
reaction mixture containing endosomal PPPase and 32P- ings are entirely consistent with above data from cell-
labeled N protein are summarized in Table 2. For making free assays, which demonstrated that R1 can inhibit the
valid comparisons between various experiments as to dephosphorylation of N.
the amount of [32P] hydrolyzed, the data were calculated
and expressed as percentage dephosphorylation per DISCUSSION
standard 25 mg quantity of endosomal protein. The maxi-
The multifactorial control over replication of coronavi-mum [32P] released from N was not above 50%, but usu-
ruses in the CNS has been of continuing interest in thisally 30–40% of the [32P] residues were solubilized. It is
laboratory. One of the most challenging aspects in virus–evident that presence of either holoenzyme PK1 or PK2
cell interactions concerns the influence of differentiationhad no inhibitory effect on the dephosphorylation reac-
on the infectability of oligodendrocytes by JHMV. Whention. Inclusion of cAMP along with the holoenzymes,
this cell type is driven toward differentiation by modulat-which brings about PK dissociation into R and C subunits,
ing the adenylate cyclase pathway, resistance becomesresulted in a minor inhibition of [32P] release. However,
manifested at a stage subsequent to adsorption and in-addition of the purified R1 subunit, whether in the ab-
ternalization but antecedent to expression of the viralsence or presence of cAMP, reduced PPPase more pro-
genome. Since the restriction in mature oligodendrocytesfoundly, but addition of the C subunit had no effect. These
of JHMV could be circumvented by transfecting into themresults imply that the R subunit can inhibit directly the
isolated genomic RNA, the arrest involves an early stependosomal PPPase. A graphic confirmation of the R1
of the replication cycle. Such resistance to infection ap-effect was obtained by subjecting to autoradiography iso-
pears to be connected with regulation of the cAMP-de-topically labeled N following SDS–PAGE in 10% gels. It
pendent PK, as evident following dbcAMP treatmentis evident from Fig. 8 that N dephosphorylation, demon-
which induces abundant synthesis of R1, despite ab-strated in lane 2 was inhibited by the presence of R1, as
sence of PK1 from these cells (Beushausen et al., 1987).evident from lane 3.
Involvement of PKs was extended by our current dataThe species specificity of R1 was tested by comparing
R1 from rabbit skeletal muscle with R1 isolated from
skeletal muscle of Wistar Furth rats. At the standard con-
centration of 3 mg per reaction mixture, the rabbit and
rat subunits inhibited endosomal PPPase to the same
extent (data not shown).
The consequence of overexpressing R1 on the MW of FIG. 8. Inhibition of N dephosphorylation by the endosomal PPPase
in the presence of R1. In the autoradiogram the signal is due to 32P-N and JHMV replication
labeled associated with N protein of JHMV. Lane 1, N in the absence
The above evidence that R1 can inhibit endosomal- of PPPase; lane 2, following reaction for 90 min at 307; lane 3 as in
lane 2 but in the presence of 3 mg R1.PPPase activity in vitro and may affect virus replication
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and Flintoff, 1987; Yokomori et al., 1993) and facilitation
of the uncoating process (Asanaka and Lai, 1993; Beus-
hausen et al., 1987; Flintoff and van Dinter, 1989; Kooi
et al., 1988). Other evidence from several laboratories
supports the view that MHVs, including JHMV, can pene-
trate by receptor-mediated endocytosis into vesicles pos-
sessing the structure of ‘‘coated pits’’ (David-Ferreira and
Manakar, 1965; Flintoff and van Dinter, 1989; Krzystyniak
and Dupuy, 1984; Mizzen et al., 1985). The current study
reveals that dephosphorylation of N from inoculum viri-
ons is most probably catalyzed by a PPPase associated
with endosomes. Combined evidence from this study and
a previous investigation (Mohandas and Dales, 1991)
characterized the relevant PPPase as one which func-
tions optimally at neutral pH and is sensitive to okadaic
acid and calyculin A, two inhibitors of phosphatases type
1 and 2A. These observations led us to the hypothesis
that JHMV uncoating may be initiated within early endo-
somes. The uncoating process whereby the RNA ge-
nome dissociates from the capsid N protein, follows de-
phosphorylation and subsequent breakdown of N. Pre-
sumably, the relevant endosomal PPPase is maximally
active at neutrality, the pH milieu likely to prevail on the
cytosolic face of the membrane, regardless of the pH
optimum for virus–cell membrane fusion (Gallagher et
al., 1991; Kooi et al., 1988). Latency of this PPPase, i.e.,
it becomes more active after solubilization of mem-
branes, as demonstrated in Mohandas and Dales (1991),
implies that in host cells the enzyme occurs in mem-
branes at a site where it can function to dephosphorylate
N as the N-RNA complex is released from inoculum viri-FIG. 9. Influence of overexpression of R1 on JHMV replication. Stable
ons. It has been suggested by Stohlman et al. (1983) thattransfected clones of L-2 cells overexpressing the R1 subunit were
identified. (A) Clones 1.1, 1.2 and normal L-2 cells were infected with the conformation of N is drastically altered according to
JHMV. Two hours postinfection, samples were processed for immu- its state of phosphorylation. By catalyzing the removal of
noblotting with anti-N antibodies: lane 1, normal L cells; lane 2, clone
phosphorus residues, the endosomal PPPase may effect1.1; lane 3, clone 1.2. The location of 56- and 50-kDa N is indicated by
the requisite conformation change to bring about separa-the arrows. (B) Supernatant was collected 8 hr postinfection and the
tion of N capsid from the genome, antecedent to hydroly-cells were assayed for PFU of virus produced. (C) Equivalent amount
of cell material was processed for immunoblotting with anti-R1 antibod- sis of this protein. Thus an inhibition of the endosomal
ies, as above. PPPase becomes directly relevant to interference with
the uncoating process of JHMV.
Based on the assumption that dephosphorylation of Nshowing that application of specific PK inhibitors can
counteract the dbcAMP effect so as to maintain the oligo- and release of the viral genome are connected, it is quite
possible that JHMV uncoating is depressed in maturedendrocytes in a permissive state, depending on both
the concentration of dbcAMP inducer used and inhibitor oligodendrocytes because R1 synthesis is upregulated,
as demonstrated by Beushausen et al. (1987). This con-affinity for the PKs. While data from studies employing
inhibitors do not provide unambiguous identification as cept has support from our in vitro experiments and those
of Jurgensen et al. (1985), Khatra et al. (1985), and Sriva-to which among the various cellular PKs is pertinent to
JHMV, our previous investigation (Beushausen et al., stava et al. (1988), who demonstrated that R can inhibit
PPPase, including the endosomal enzyme. One should1987) indicated that neither the type C or cGMP-depen-
dent PK’s are involved in controlling the infection. not, however, overlook other metabolic derangements
effected by R, including a reduction in the basal levelData obtained from other studies, among them cell
fusion analyses, demonstrated that other cellular factors of cAMP-responsive transcription (Mellon et al., 1989;
Shenolikar, 1994); however, in the present context, anapart from the presence of specific viral receptors are
required for JHMV penetration (Asanaka and Lai, 1993; effect by R on transcription does not explain the resis-
tance manifested by mature oligodendrocytes becauseFlintoff and Van Dinter, 1989; Kooi et al., 1988; van Dinter
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Flockhart, D. A., and Corbin, J. D. (1982). Regulatory mechanisms inearly block to infection can be circumvented by transfec-
the control of protein kinases. Crit. Rev. Biochem. 12, 133–186.tion with free JHMV RNA.
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